Exelon backs FY23 adjusted EPS view $2.30-$2.42, consensus $2.37

Reaffirming fully regulated operating EPS compounded annual growth target of 6%-8% from 2021 and 2022 guidance midpoints through 2025 and 2026, respectively, with expectation to be at midpoint or better of growth range.